SYSTM Wealth Solutions’s Vertex Pharmaceuticals VRTX Stock Holding History

SYSTM Wealth Solutions’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$1.4K	Sell	3 -171	-98%	-$82.1K	0.04%	67
2024 Q2	$81.6K	Sell	174 -1,140	-87%	-$495K	0.02%	252
2024 Q1	$549K	Sell	1,314 -1,008	-43%	-$426K	0.07%	275
2023 Q4	$945K	Buy	2,322 +34	+1%	+$12.6K	0.13%	202
2023 Q3	$796K	Buy	2,288 +415	+22%	+$145K	0.12%	215
2023 Q2	$659K	Sell	1,873 -322	-15%	-$108K	0.09%	275
2023 Q1	$692K	Buy	2,195 +580	+36%	+$174K	0.11%	232
2022 Q4	$466K	Buy	+1,615	New	+$492K	0.06%	356

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

SYSTM Wealth Solutions's VRTX Position: Q3 2024 in Review

SYSTM Wealth Solutions reduced its Vertex Pharmaceuticals (VRTX) stake by 98% in Q3 2024, selling an estimated $82.1K and leaving 3 shares worth $1.4K. The position accounts for 0.04% of the portfolio, ranked #67.

SYSTM Wealth Solutions first reported a position in VRTX in Q4 2022 and has held it in 8 quarters since. The position peaked at $945K in Q4 2023. 1,544 funds tracked by Wall St. Rank hold VRTX as of Q3 2024.

SYSTM Wealth Solutions held 3 shares of Vertex Pharmaceuticals worth $1.4K as of Q3 2024.
SYSTM Wealth Solutions sold 171 Vertex Pharmaceuticals shares in Q3 2024, an estimated $82.1K.
Vertex Pharmaceuticals made up 0.04% of SYSTM Wealth Solutions's portfolio in Q3 2024, its #67 holding.
SYSTM Wealth Solutions first reported a position in Vertex Pharmaceuticals in Q4 2022 and has held it in 8 quarters since.
SYSTM Wealth Solutions's Vertex Pharmaceuticals position peaked at $945K in Q4 2023.
1,544 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2024.

Based on SYSTM Wealth Solutions's 13F filing for Q3 2024, filed 14 Nov 2024.